Groups | Glucose level (mg/dl) | ||||||
---|---|---|---|---|---|---|---|
Oth day | 3rd day | 6th day | 9th day | 12th day | 15th day | % variance | |
Normal control | 110.5 ± 14 | 99.83 ± 17 | 99.33 ± 18 | 102.2 ± 28 | 107.5 ± 3 | 109.2 ± 2 | 4.69% |
Diabetic control | 333.7 ± 1* | 344.0 ± 2* | 345.3 ± 22* | 335.8 ± 40* | 358.0 ± 20* | 374.7 ± 16* | 6.80% |
Normal Zf treated | 111.2 ± 13 | 107.5 ± 15 | 104.5 ± 16 | 98.67 ± 14 | 98.33 ± 14 | 78.83 ± 34** | 11.46% |
Diabetic Zf treated | 334.2 ± 44.6 | 298.0 ± 1* | 255.8 ± 25* | 250.0 ± 30* | 234.8 ± 2* | 215.8 ± 30* | 16.48% |
Normal Zb. Treated | 114.0 ± 15. | 109.7 ± 13 | 112.7 ± 13 | 101.3 ± 12 | 94.67 ± 10 | 94.5 ± 12 | 8.47% |
Diabetic Zb treated | 279.8 ± 36 | 265.8 ± 3* | 259.2 ± 38* | 252.2 ± 35* | 246.3 ± 3* | 239.2 ± 33* | 5.65% |
Normal Zl treated | 106.8 ± 17 | 105.3 ± 15 | 108.8 ± 17 | 99.6 ± 14 | 100.2 ± 11 | 98.83 ± 14 | 4.09% |
Diabetic Zl treated | 325.2 ± 26 | 234.0 ± 3* | 188.8 ± 36* | 154.0 ± 23* | 147.5 ± 2* | 123.7 ± 18* | 37.95% |
Diabetic Glibenclamide treated | 320.7 ± 22 | 271.5 ± 18* | 215.7 ± 18* | 154.2 ± 18* | 163.0 ± 1* | 136.3 ± 17* | 34.84% |